Postoperative Nausea and Vomiting (PONV)

Preventing PONV shortens postoperative recovery and was identified as one of four statistically significant independent predictors of recovery duration. PONV prevention is both a cost-increasing ERAS measure and the measure with the most impact on recovery speed, with the smallest cost increase among the five cost-increasing measures. PONV incidence in surgical patients is 30–80%, and gynaecological patients are a particularly high-risk group due to female sex, laparoscopic procedures, and non-smoker status. Prophylactic antiemetic use during surgery is recommended for all abdominal surgery patients.